Citation Impact
Citing Papers
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
2015 Standout
Differential diagnosis of suspected multiple sclerosis: a consensus approach
2008
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
2005 Standout
The clinical symptoms of Parkinson's disease
2016 Standout
The phenomenology and treatment of interferon-induced depression
2004
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Differential diagnosis and evaluation in pediatric multiple sclerosis
2007
Astrocytes: biology and pathology
2009 Standout
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures
2011
Mortality from multiple sclerosis in Austria 1970–2001: dynamics, trends, and prospects
2004
Isolated Neurosarcoidosis
2012
Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features
2008
Sjögren's syndrome
2005 Standout
The spectrum of neuromyelitis optica
2007 Standout
Neuromyelitis optica: what it is and what it might be
2003
An epidemiological study of neuromyelitis optica in Cuba
2009
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First Revision
2010 Standout
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
2011 StandoutNature
Parkinson's disease: clinical features and diagnosis
2008 Standout
TFOS DEWS II Diagnostic Methodology report
2017 Standout
Degenerative Cervical Myelopathy
2015 Standout
Clinical and magnetic resonance imaging manifestations of neurosarcoidosis
2005
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome
2016 Standout
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Cognitive impairment in multiple sclerosis
2008 Standout
Natural history of multiple sclerosis
2005
Diagnosis of multiple sclerosis: progress and challenges
2016
Lupoid sclerosis
2009
Cervical Spondylotic Myelopathy
2010
Neurological Involvement in Primary Sjögren Syndrome: A Focus on Central Nervous System
2014
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson’s disease
2007
Sarcoidosis
2013 Standout
Multiple sclerosis
2008 Standout
Characterization of cognitive dysfunction in Sjögren’s syndrome patients
2013
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
The Pathology of MS
2007
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Brain abnormalities in neuromyelitis optica
2011
Conventional Therapy of Sjogren’s Syndrome
2007
Differentiating drusen: Drusen and drusen-like appearances associated with ageing, age-related macular degeneration, inherited eye disease and other pathological processes
2016
Age-related macular degeneration
2018 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Clinical characteristics, course and prognosis of relapsing Devic?s Neuromyelitis Optica
2004
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
2011 Standout
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
2010 Standout
Major Depressive Disorder
2008 Standout
Tryptophan degradation in autoimmune diseases
2007
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
2006
Pulmonary Arterial Hypertension: A Rare Complication of Primary Sjögren Syndrome
2007
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
2013 Standout
Depression in multiple sclerosis: a review
2005
Aggressive Therapy for Neurosarcoidosis
2007
Brain Abnormalities in Neuromyelitis Optica
2006
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness
2010 Standout
Progressive necrotizing myelopathy: part of the spectrum of neuromyelitis optica?
2006
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Postural deformities in Parkinson's disease
2011
Sarcoidosis
2007 Standout
Long-term Follow-up of Acute Partial Transverse Myelitis
2012
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness
2006
The molecular neurobiology of depression
2008 StandoutNature
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 Standout
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
2005 Standout
Spinal cord MRI in multiple sclerosis—diagnostic, prognostic and clinical value
2015
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
2008
Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis
2006
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Neuromyelitis optica: a distinct demyelinating disease of the central nervous system
2008
Neuromyelitis optica with hypothalamic involvement
2005
Revised diagnostic criteria for neuromyelitis optica
2006 Standout
Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy
2008
A population-based study of neuromyelitis optica in Caucasians
2011
An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion
2005
Multiple Sclerosis
2018 Standout
Autonomic Dysregulation, Cognitive Impairment, and Symptoms of Psychosis as an Unusual Presentation in an Anti-Aquaporin 4-Positive Patient.
2017 Standout
Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis
2009
The rising prevalence and changing age distribution of multiple sclerosis in Manitoba
2010 Standout
Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica.
2006
Devic’s neuromyelitis optica: a critical review
2008
Cognitive impairment in relapsing—remitting multiple sclerosis can be predicted by imaging performed several years earlier
2007
Evidence-based guideline: Clinical evaluation and treatment of transverse myelitis: [RETIRED]
2011
NMO-IgG and Devic's neuromyelitis optica: a French experience
2008
The Emerging Link Between Autoimmune Disorders and Neuropsychiatric Disease
2011
Catalytic Asymmetric Transacetalization
2010 StandoutNobel
Idiopathic Transverse Myelitis and Neuromyelitis Optica: Clinical Profiles,Pathophysiology and Therapeutic Choices
2011
Direct Catalytic Asymmetric Synthesis of Cyclic Aminals from Aldehydes
2008 StandoutNobel
Occurrence of acute large and edematous callosal lesions in neuromyelitis optica
2009
Works of D. Ferriby being referenced
CSF isoelectrofocusing in a large cohort of MS and other neurological diseases
2004
A specific clinical pattern of camptocormia in Parkinson's disease
2006
Kjellin Syndrome: Long-term Neuro-ophthalmologic Follow-up and Novel Mutations in the SPG11 Gene
2010
Prospective study of patients presenting with acute partial transverse myelopathy
2003
Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile
2002
Neurologic Manifestations in Primary Sjögren Syndrome
2004
Brain MRI in late‐onset multiple sclerosis
2005
Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis
2003
[Chronic polyradiculoneuritis disclosing sarcoidosis].
2002
One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis
2005
[Clinical manifestations and therapeutic approach in neurosarcoidosis].
2000
Unusual MR findings of the brain stem in arterial hypertension.
2000
Multiple sclerosis and depression: influence of interferon b therapy
2003
Long-term follow-up of neurosarcoidosis
2001
Myelopathies secondary to Sjögren's syndrome: treatment with monthly intravenous cyclophosphamide associated with corticosteroids.
2006
The prevalence of Sjogren syndrome in patients with primary progressive multiple sclerosis
2001